Current Report Filing (8-k)
October 19 2016 - 4:20PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Earliest Event Reported): October 15, 2016
CYTRX
CORPORATION
(Exact
Name of Registrant as Specified in its Charter)
Delaware
(State
or Other Jurisdiction of Incorporation)
000-15327
(Commission
File Number)
|
58-1642740
(I.R.S.
Employer Identification No.)
|
11726
San Vicente Boulevard, Suite 650
Los
Angeles, California
(Address
of Principal Executive Offices)
|
90049
(Zip
Code)
|
(310)
826-5648
(Registrant’s
Telephone Number, Including Area Code)
______________________________
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02
|
Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Director Resignation
On
October 15, 2016, Cheryl Cohen resigned for personal reasons as a director of CytRx Corporation.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CYTRX CORPORATION
|
|
|
Date: October
19, 2016
|
By:
|
/s/
JOHN Y. CALOZ
|
|
|
Name: John
Y. Caloz
Title: Chief Financial Officer
|
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Apr 2024 to May 2024
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Cytrx Corp. (MM) (NASDAQ): 0 recent articles
More Cytrx Corp News Articles